Latest Europe News

BPH Energy’s September quarter report highlights pivotal developments across its investees, from a critical judicial review in offshore petroleum to breakthroughs in AI medical devices and clean hydrogen production.

Control Bionics reports a strong start to FY26 with nearly 10% revenue growth, expanded US reimbursement coverage, and advancing commercialization of its NeuroNode and NeuroStrip technologies.

Titomic Limited has launched a major European manufacturing hub and a UK subsidiary, secured a $50 million capital raise, and forged strategic partnerships to advance its cold spray additive manufacturing technology.

Battery Age Minerals has secured a significant germanium-gallium asset in Utah, marking its strategic entry into the US market and complementing its European portfolio. The move aligns with growing Western efforts to secure critical semiconductor metals.

Latitude 66 Limited has completed the sale of its 17.5% interest in the Greater Duchess Joint Venture to Carnaby Resources, transforming its balance sheet to a debt-free position with $6.4 million in cash and shares. Meanwhile, promising exploration results at its Australian gold projects and a new cobalt processing agreement in Finland set the stage for growth.

GreenX Metals has revealed a substantial historical copper estimate at its Tannenberg project in Germany, alongside promising antimony-gold findings in Greenland and a major arbitration award against Poland.

Berkeley Energia reports promising lithium and rubidium recoveries from its Conchas Project in Spain, while its subsidiary pursues a $1 billion arbitration claim against Spain over regulatory hurdles at the Salamanca uranium project.

Elementos Limited advances its Oropesa Tin Project in Spain and Cleveland Tin Project in Tasmania, securing a binding option to acquire 50% of a Spanish tin smelter, positioning itself as the European Union’s primary vertically integrated tin producer amid strong tin prices.

Bioxyne Limited has reported a record-breaking first quarter for FY26, with revenues soaring 210% year-on-year, driven by strong demand in cannabis products and strategic European market advances.

Biotron Limited has advanced its Hepatitis B antiviral program while preparing to acquire Sedarex Limited, backed by a $2.5 million capital raise. The move signals a strategic expansion into safer anaesthetics alongside ongoing R&D progress.

Ava Risk Group reported a 5% revenue increase in FY2025, driven by its Detect segment and a strong sales backlog. The company targets over 20% revenue growth in FY2026, supported by its Aura Ai-X fibre optic sensing technology and strategic global partnerships.

Altech Batteries has launched immediate sales of sodium nickel chloride batteries through a strategic collaboration with AMPower, while advancing its flagship CERENERGY project in Germany with strong funding and prototype milestones.